Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
No published trial preclinical or human has tested BPC-157 + TB-500 together
A study examining GHK's effects on human breast cancer MCF7 and prostate cancer PC3 cell lines found gene expression changes consistent with reduced proliferative and invasive capacity
This decline is closely linked to the loss of skin repair capacity and decreased dermal collagen density
Any part of the body can be affected, but most loose skin complaints center around the arms, thighs, abdomen and hips/buttocks
Some peptides are FDA-approved medicines used for decades, while others are experimental compounds still being studied
BPC-157 has demonstrated systemic activity when administered orally (in some models), though subcutaneous delivery is most commonly used in the published literature
)
)
US$ 21.01
US$ 28.20
US$ 23.94
